System.Func`1[System.String]

How Biosimilars Differ from Biologics in Cost and Benefits

Increased affordability of biosimilars may have an impact on healthcare systems.

By McKesson Health Systems Editorial Team

Date

August 01, 2022

Scientist sits in a lab, there is a microscope on the table

By: McKesson Medical Surgical Editorial Team

Read time: 1 minute

An overview of biosimilars and how they compare to biologics

Health systems and clinics considering the adoption of biosimilars for treatment should understand and consider how they compare to biologics. Biosimilar products are therapies that have the same therapeutic value and potency as their biologic counterparts, the use of biosimilar drugs may save money for both patients and providers. Increased affordability of the biosimilars may also have a meaningful impact on the healthcare system.

To learn more, read What are biosimilars? How biosimilars differ from biologics in cost & benefits.

Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Subscribe

Related Stories

Magnifying glass over a yellow checkmark inside a white square on a blue background.

Answering these questions can help differentiate transactional vendor relationships from strategic partnerships that add value.

Read More

Person in a suit standing by a window, holding a smartphone with earphones connected.

The most downloaded content by health system pharmacy leaders in October 2025.

Read More

American Pharmacists Month Wrap Up title

Take another opportunity to recognize and celebrate the impactful work of pharmacists as October comes to a close.

Read More

Close-up of a professional microphone in a shock mount with a blurred computer screen in the background.

McKesson’s Intrafusion expert discusses the measurable impacts of a successful infusion service line in health systems.

Read More

People in business attire interacting and shaking hands at a professional networking event.

Connect with our experts and industry leaders to uncover strategies to help you achieve more.

Read More

Person in blue scrubs organizing medical supplies on shelves in a well-lit room with cabinets and a microwave.

Join us in taking this opportunity to celebrate the contributions of pharmacy technicians, whose training and professionalism support positive outcomes.

Read More

A group of people seated around a conference table in a modern office with large windows, engaged in discussion.

McKesson leaders attending a C-Suite dialogue on leveraging ambulatory pharmacy settings.

Read More

Expert Q&A: The Value of Strategic Partnership Beyond Price, with people in a professional setting and a laptop.

Explore the value a strategic partnership can bring in helping take your health system pharmacy further to achieve more.

Read More

Interactive 340B and IRA Resource Library text on a background with light blue and yellow geometric shapes.

Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.

Read More

Two people in a warehouse with overlaid text: "Advanced Therapies Require End-to-End Visibility and Communication in the Supply Chain."

Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.

Read More